Vaccination with transgenic rice seed expressing mite allergen: a new option for asthma sufferers?
- 1 September 2011
- journal article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 10 (9) , 1249-1251
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Functions of T cells in asthma: more than just TH2 cellsNature Reviews Immunology, 2010
- Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptidesPeptides, 2010
- Hypersensitivity and oral tolerance in the absence of a secretory immune systemAllergy, 2010
- Development of Transgenic Rice Expressing Mite Antigen for a New Concept of ImmunotherapyInternational Archives of Allergy and Immunology, 2009
- A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responsesProceedings of the National Academy of Sciences, 2005
- Advances in upper airway diseases and allergen immunotherapyJournal of Allergy and Clinical Immunology, 2005
- Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: Major conformational IgE epitopes blocked by prodomainsJournal of Allergy and Clinical Immunology, 2005
- Therapeutic potential of oral toleranceNature Reviews Immunology, 2004
- Mite faeces are a major source of house dust allergensNature, 1981